Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

PRO MEDICUS UNSPON ADS EACH REP (PMDIY)

Compare
13.25
0.00
(0.00%)
At close: April 16 at 10:05:39 AM EDT
Loading Chart for PMDIY
  • Previous Close 13.25
  • Open 13.25
  • Bid --
  • Ask --
  • Day's Range 13.25 - 13.25
  • 52 Week Range 13.25 - 13.25
  • Volume 100
  • Avg. Volume 100
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.48
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Feb 28, 2025
  • 1y Target Est --

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.

www.promed.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PMDIY

View More

Compare To: PMDIY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PMDIY

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    13.07B

  • Enterprise Value

    12.96B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    53.25%

  • Return on Assets (ttm)

    32.90%

  • Return on Equity (ttm)

    51.53%

  • Revenue (ttm)

    184.58M

  • Net Income Avi to Common (ttm)

    98.29M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    182.33M

  • Total Debt/Equity (mrq)

    0.82%

  • Levered Free Cash Flow (ttm)

    84.17M

Research Analysis: PMDIY

View More

Company Insights: PMDIY

Research Reports: PMDIY

View More